Printer Friendly

Printed from http://www.researchandmarkets.com/reports/1495870

Eisai Inc. - Strategic SWOT Analysis Review

Description:
Eisai Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Our summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.

Highlights

Eisai Inc. (Eisai) is a healthcare company with focus on the discovery, development and marketing of pharmaceutical products. The company's major products include Aricept for Alzheimer’s treatment, Aciphex for acid reflux, Aloxi anti-nausea medication injection, Belviq diet drug, Dacogen for the treatment of myelodysplastic syndromes, Banzel for adjunctive treatment, Fragmin low molecular weight heparin, Ontak antineoplastic agent, Panretin for the treatment of skin lesions in AIDS-related Kaposi's sarcoma and Zonegran treating partial seizures in adults with epilepsy. The company’s research and development activities focus on therapeutic areas such as neurology, gastrointestinal disorders, oncology and acute care. Eisai established partnerships and collaborations with global companies such as Pfizer Inc., Janssen Pharmaceutica Inc., and Elan Pharma International Limited and Elan Pharmaceutical Inc for the development and distribution of drugs. The company is a subsidiary of Eisai Co., Ltd. and is headquartered in New Jersey, the US.

Eisai Inc. Key Recent Developments

Jun 13, 2014: Eisai Sponsors the Epilepsy Foundation of Metropolitan New York's 2nd Annual Epilepsy Awareness Day at Citi Field
May 14, 2014: Eisai Highlights New Research at 50th ASCO Annual Meeting
Mar 10, 2014: Eisai Announces Retirement of President and CEO
Aug 15, 2013: Eisai Launches New Website Providing Employers with Educational Resource for Obesity Management
Mar 05, 2013: DSM Pharma Signs Master Supply Agreement With Eisai

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with Our detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.
 
Contents:
List of Tables
List of Figures
Section 1 - About the Company
Eisai Inc. - Key Facts
Eisai Inc. - Key Employees
Eisai Inc. - Key Employee Biographies
Eisai Inc. - Major Products and Services
Eisai Inc. - History
Eisai Inc. - Company Statement
Eisai Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Eisai Inc. - Business Description
Eisai Inc. - SWOT Analysis
SWOT Analysis - Overview
Eisai Inc. - Strengths
Strength - Strong In-house Research Expertise
Strength - Product Collaboration with Leading Players
Strength - Diversified Product Portfolio
Eisai Inc. - Weaknesses
Weakness - Weak Financial Performance
Eisai Inc. - Opportunities
Opportunity - Agreements & Collaborations
Opportunity - Market Potential – Obesity
Opportunity - Strategic Initiatives
Opportunity - Orphan Drug Designation
Eisai Inc. - Threats
Threat - Intense Competition
Threat - Litigation Claims
Threat - Stringent Government Regulations
Eisai Inc. - Key Competitors
Section 3 – Company’s Lifesciences Financial Deals and Alliances
Eisai Inc., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
Eisai Inc., Pharmaceuticals & Healthcare, Deals By Type, 2008 to YTD 2014
Eisai Inc., Recent Deals Summary
Section 4 – Company’s Recent Developments
Jun 13, 2014: Eisai Sponsors the Epilepsy Foundation of Metropolitan New York's 2nd Annual Epilepsy Awareness Day at Citi Field
May 14, 2014: Eisai Highlights New Research at 50th ASCO Annual Meeting
Mar 10, 2014: Eisai Announces Retirement of President and CEO
Aug 15, 2013: Eisai Launches New Website Providing Employers with Educational Resource for Obesity Management
Mar 05, 2013: DSM Pharma Signs Master Supply Agreement With Eisai
Section 5 – Appendix
Methodology
About Us
Contact Us
Disclaimer

List of Tables
Eisai Inc., Key Facts
Eisai Inc., Key Employees
Eisai Inc., Key Employee Biographies
Eisai Inc., Major Products and Services
Eisai Inc., History
Eisai Inc., Other Locations
Eisai Inc., Subsidiaries
Eisai Inc., Key Competitors
Eisai Inc., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
Eisai Inc., Pharmaceuticals & Healthcare, Deals By Type, 2008 to YTD 2014
Eisai Inc., Recent Deals Summary

List of Figures
Eisai Inc., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
Eisai Inc., Pharmaceuticals & Healthcare, Deals by Type, 2008 to YTD 2014
 
Companies Mentioned
Abraxis BioScience, Inc.
Salix Pharmaceuticals, Ltd.
AstraZeneca PLC
Koronis Pharmaceuticals, Inc.
Predictive Biosciences, Inc.
Ceregene, Inc.
Adlyfe Inc.
 
Ordering:
Order Online - visit http://www.researchandmarkets.com/reports/1495870

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.

 
Page 1 of 2
Printed Dec 22, 2014
5:58:39 PM

Fax order form

To place a fax order simply print this form, fill in and fax the completed form to the number below. If you have any questions please email help@researchandmarkets.net

Order information

Please verify that the product information is correct and select the format you require.

Product name

Eisai Inc. - Strategic SWOT Analysis Review

Web Address

http://www.researchandmarkets.com/reports/1495870

Office Code

SCOI7T

 

Report Formats

Please enter the quantity of the report format you require.

Format Quantity Price
Electronic (PDF) - Single User USD 125
Electronic (PDF) - Site License USD 250
Electronic (PDF) - Enterprisewide USD 375

Contact information

Please enter all the information below in block capitals.

Title:
Mr Mrs Dr Miss Ms Prof
First Name:
Last Name:
Email Address:
Job Title:
Organisation:
Address:
City:
Postal / Zip Code:
Country:
Phone Number:
Fax Number:

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)

Page 2 of 2
Printed Dec 22, 2014
5:58:39 PM

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

Pay by Credit Card:

American Express

Diners Club

Master Card

Visa

Cardholder's Name:
Cardholder's Signature:
Expiry Date:
/
Card Number:
CVV Security Code:
Issue date:
/ (Diners Club only)
 
Pay by Check:

Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.

 
Pay by Wire Transfer:

Please transfer funds to:

Account Number:
83313083
Sort Code:
98-53-30
Swift Code:
ULSBIE2D
IBAN Number:
IE78ULSB98533083313083
Bank Address:
Ulster Bank,
27-35 Main Street
Blackrock,
Co. Dublin
Ireland.
 

If you have a Marketing Code please enter it below:

Marketing Code:

Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)